Skip to main content
. 2013 Sep 2;5:437–445. doi: 10.2147/CEOR.S47486

Figure 3.

Figure 3

One-way sensitivity analyses.a,b

Notes: aIncorporating 3% annual discount rate for cost, LY, and QALY outcomes. Results expressed in $/QALY for Stribild™ compared with Atripla®; ball parameters were varied by ±10%; cStribild™ had higher costs and lower QALYs than Atripla®.

Abbreviations: AE, adverse event; AIDS, acquired immune deficiency syndrome; AKI, acute kidney injury; CKD, chronic kidney disease; LY, life year; QALY, quality-adjusted life year.